{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:51:50Z","timestamp":1773780710597,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4923,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1995,11]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> <jats:sc>l<\/jats:sc>\u2010Asparaginase treatment during induction therapy in acute lymphoblastic leukaemia (ALL) is known to be frequently complicated by thromboembolic events. It was recently suggested that <jats:sc>l<\/jats:sc>\u2010asparaginase derived from <jats:italic>Erwinia chrysanthemi<\/jats:italic> alters the coagulation system less severely than does <jats:italic>Escherichia coli<\/jats:italic> asparaginase. In a series of 11 adult patients with ALL, we investigated some parameters of the coagulation system during treatment with <jats:italic>Erwinia<\/jats:italic> asparaginase. The doses employed were rather high; all patients below the age of 60 years received 15000 U\/m<jats:sup>2<\/jats:sup> daily over 14 days. In accordance with what is known from treatment with <jats:italic>E. coli<\/jats:italic> asparaginase, we observed significant lowering of antithrombin as well as of fibrinogen. However, as to fibrinogen indeed a significant decrease had occurred prior to the institution of <jats:italic>Erwinia<\/jats:italic> asparaginase treatment. The most striking observation in the present study was that the levels of prothrombin complex, reflecting the function of K\u2010vitamin dependent coagulation factors II, VII and X, remained within normal ranges during treatment. This indicates that these coagulation factors were not affected by <jats:italic>Erwinia<\/jats:italic> asparaginase, an observation at variance with several reports where <jats:italic>E. coli<\/jats:italic> asparaginase was investigated. This latter observation was the only finding which could lend support to the view that <jats:italic>Erwinia<\/jats:italic> asparaginase affects the coagulation system less than <jats:italic>E. coli<\/jats:italic> asparaginase. Finally, one of our patients developed a sinus thrombosis, a severe thrombotic complication.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1995.tb00699.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T05:38:43Z","timestamp":1279431523000},"page":"289-293","source":"Crossref","is-referenced-by-count":29,"title":["Effects of <i>Erwinia<\/i>\u2010asparaginase on the coagulation system"],"prefix":"10.1111","volume":"55","author":[{"given":"H.","family":"Carlsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Stockelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tengborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Braide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Carneskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196911062811902"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197003262821307"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-74-6-893"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-99984-0_38"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830320105"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(90)90193-G"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb06336.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(90)90122-S"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0038-1651179","article-title":"Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose E. coli asparaginase: a GIGEMA study","volume":"69","author":"Leone G.","year":"1993","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1992.tb00032.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)91538-X"},{"key":"e_1_2_1_13_2","unstructured":"GugliottaL. MazzucconiMG LeoneG. et al.Erwinase and haemostatic system in adult acute lymphoblastis leukemia patients. Preliminary results of a GIGEMA study. Abstract from 24th Congress of Haematology London UK 1992:1470:388."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1025358"},{"key":"e_1_2_1_15_2","volume-title":"Behan\u2010dling av vuxna patienter med akut lymfatisk och akut odif\u2010ferentierad leukemi","year":"1986"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000205234"},{"key":"e_1_2_1_17_2","first-page":"702","article-title":"Thromboembolic complications associated with l\u2010asparaginase therapy","volume":"55","author":"Omer K.","year":"1985","journal-title":"Cancer"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000206887"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1989.tb01464.x"},{"key":"e_1_2_1_20_2","volume-title":"Development of Erwinase (Erwinia\u2010asparaginase)","author":"Wade HE.","year":"1983"},{"key":"e_1_2_1_21_2","first-page":"1517","article-title":"Transient dys\u2010fibrinogenemia and cerebral thrombosis following remission induction therapy for acute lymphoblastic leukemia","volume":"31","author":"Kubota A.","year":"1990","journal-title":"Rinso-Ketsueki"},{"key":"e_1_2_1_22_2","first-page":"1037","article-title":"Transient hypofibrinogenemia induced by prednisolone in a case of acute lymphoblastic leukemia","volume":"30","author":"Fujieda H.","year":"1989","journal-title":"Rinsho-Ketsueki"},{"issue":"1","key":"e_1_2_1_23_2","first-page":"6","article-title":"Plasma measurement of D\u2010dimer as diagnostic aid in suspected venous thromboembolism: an overview","volume":"71","author":"Bounameaux H.","year":"1994","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199402000-00004"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1995.tb00699.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1995.tb00699.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:20:43Z","timestamp":1695907243000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1995.tb00699.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["10.1111\/j.1600-0609.1995.tb00699.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1995.tb00699.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,11]]}}}